Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare
Aclaris Therapeutics, Inc. Revenue 2017–2025
Aclaris Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aclaris Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 2.0 M, a 37.18% increase year-over-year.
- Aclaris Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 8.5 M, a 54.62% decrease year-over-year.
- Aclaris Therapeutics, Inc. annual revenue for 2025 was 7.8 M, a 58.19% decrease from 2024.
- Aclaris Therapeutics, Inc. annual revenue for 2024 was 18.7 M, a 40.09% decrease from 2023.
- Aclaris Therapeutics, Inc. annual revenue for 2023 was 31.2 M, a 5.03% increase from 2022.
- Aclaris Therapeutics, Inc. annual revenue for 2022 was 29.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aclaris Therapeutics, Inc. Market Cap — FAQ
Aclaris Therapeutics, Inc. (ACRS) market cap over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACRS's market cap history?
The chart and table above show Aclaris Therapeutics, Inc.'s market cap by year and by quarter, including the growth rate.